Compound ID | 2253
Class: Antimicrobial peptide
| Agent Type: | Natural product; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Hypothesized to inhibit nucleic acid synthesis |
| Target Pathogen: | Active against Clostridia sp., Staphylococcus aureus, Enterococcus faecalis, and Bacillus subtilis |
| Description: | Natural product from Ruminococcus gnavus E1, a human gut symbiont; sactipeptide-type |
| Year first mentioned: | 2019 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://www.science.org/doi/10.1126/sciadv.aaw9969 |